Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China-Reference-Cited by-同舟云学术

Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China

Published:2022-12-14 Issue: Volume: Page:
ISSN:1123-6337
Container-title:Techniques in Coloproctology
language:en
Short-container-title:Tech Coloproctol

Author:

Zhou Sicheng,Mei Shiwen,Feng Bo,Yang Yingchi,Wang Xin,Wang Quan,Liu Qian^ORCID

Funder

the National Key Research and Development Program/Prevent and Control Research for Important Non-Communicable Diseases

the Medicine and Health Technology Innovation Project of the Chinese Academy of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10151-022-02746-2.pdf

Reference24 articles.

1. Akiyoshi T, Watanabe T, Miyata S et al (2012) Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?: Is it regional or distant disease? Ann Surg 255(6):1129–1134. https://doi.org/10.1097/SLA.0b013e3182565d9d

2. Sugihara K, Kobayashi H, Kato T et al (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49(11):1663–1672. https://doi.org/10.1007/s10350-006-0714-z

3. Yano H, Moran BJ (2008) The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West. Br J Surg 95(1):33–49. https://doi.org/10.1002/bjs.6061

4. Bosset JF, Calais G, Mineur L et al (2014) Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 15(2):184–190. https://doi.org/10.1016/S1470-2045(13)70599-0

5. Fujita S, Mizusawa J, Kanemitsu Y et al (2017) Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg 266(2):201–207. https://doi.org/10.1097/SLA.0000000000002212